Author:
Revuelta-López E,Lupón J,Lax A,Pascual-Figal DA,Bayés-Genís A
Funder
Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Cardiology and Cardiovascular Medicine,Pharmaceutical Science,Genetics,Molecular Medicine
Reference5 articles.
1. Haugen, E., Gan, L. M., Isic, A., Skommevik, T., & Fu, M. (2008). Increased interleukin-6 but not tumour necrosis factor-alpha predicts mortality in the population of elderly heart failure patients. Experimental & Clinical Cardiology, 13(1), 19–24.
2. Kosar, F., Aksoy, Y., Ozguntekin, G., Ozerol, I., & Varol, E. (2006). Relationship between cytokines and tumour markers in patients with chronic heart failure. European Journal of Heart Failure, 8(3), 270–274.
3. Pascual-Figal, D. A., Bayes-Genis, A., Asensio-Lopez, M. C., Hernández-Vicente, A., Garrido-Bravo, I., Pastor-Perez, F., Díez, J., Ibáñez, B., & Lax, A. (2019). The interleukin-1 axis and risk of death in patients with acutely decompensated heart failure. Journal of the American College of Cardiology, 73(9), 1016–1025.
4. Bayés-Genís, A., Núñez, J., & Lupón, J. (2017). Soluble ST2 for prognosis and monitoring in heart failure: the new gold standard? Journal of the American College of Cardiology, 70(19), 2389–2392.
5. Ridker, P. M., Everett, B. M., Thuren, T., et al. (2017). Antiinflammatory therapy with canakinumab for atherosclerotic disease. The New England Journal of Medicine, 377, 1119–1131.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献